小臻臻 發問時間: 社會與文化語言 · 1 0 年前

求助護理英文文獻翻譯

NEUROPROTECTIVE AGENTS IN CEREBRAL ISCHEMIA

CONCLUSIONS

There is no longer a place for therapeutic nihilism in the treatment of strokes, for ischemic strokes are both responsive to primary and secondary prevention and to acute therapeutic interventions. At the current time, thrombolytic therapy for eligible patients with acute ischemic stroke shows good potential for improving the long-term quality of life of reducting disability. Moreover, currently-underway the Phase II and III trials of several neuroprotective agents carry a hope that in the new millennium all patients with acute stroke will receive some form of intervention helping limit the disability and devastation caused by the dreading disease. Therefore, patients should be informed about not only the treatment risks but also the risks of not being treated, as part of the informed-consent process.

2 個解答

評分
  • 1 0 年前
    最佳解答

    NEUROPROTECTIVE AGENTS IN CEREBRAL ISCHEMIA

    在大腦局部缺血裡的神經保護介質

    CONCLUSIONS

    結論

    There is no longer a place for therapeutic nihilism in the treatment of strokes, for ischemic strokes are both responsive to primary and secondary prevention and to acute therapeutic interventions.

    為了治療缺血性中風,主要和次要的預防以及急性治療介入的都受影響,不再有地區為了或有或無的療效在中風的治療上

    At the current time, thrombolytic therapy for eligible patients with acute ischemic stroke shows good potential for improving the long-term quality of life of reducting disability.

    在現在,血栓溶解治療為合適的急性缺血性中風病人展現出好的潛力,在長時間減少生活殘疾的特性

    Moreover, currently-underway the Phase II and III trials of several neuroprotective agents carry a hope that in the new millennium all patients with acute stroke will receive some form of intervention helping limit the disability and devastation caused by the dreading disease.

    此外,現在進行中的第二及第三期試驗的數個神經保護介質帶著在新的黃金時代所有急性中風的病人的希望,將會得到一些形式的介入,來幫助限制殘疾以及荒廢造成的畏懼疾病

    Therefore, patients should be informed about not only the treatment risks but also the risks of not being treated, as part of the informed-consent

    process.

    因此,病人將被通知治療的風險以及沒被治療的風險,與同意被通知的過程一樣

    參考資料: 自己,Dr. eye,網路
  • 1 0 年前

    在腦局部缺血裡的NEUROPROTECTIVE代理人

    結論

    在處理打擊過程中不再有治療的虛無主義的一個地方,對ischemic來說打擊是既對主要敏感又第二預防,和對厲害的治療的干涉。 在現時,有急性的ischemic中風的合格的病患的thrombolytic治療為改進reducting 生理殘障的長期的生活質量表現好潛能。 而且, 目前進行中II 階段幾neuroprotective代理人III 審訊傳播一希望全部病患與厲害的筆畫一起的在新千年內 收到某種形式的干涉(幫助限制被畏懼的疾病引起的生理殘障和破壞)。 因此,病患應該大約不僅而且不治療,作為明智的應允過程的部分的危險的處理危險通知。

還有問題?馬上發問,尋求解答。